Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foa

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|July 28, 2016
Cellular and Molecular Characterization of Two Cases of Castleman's Disease, Plasma Cell VariantS Roncella, P F Di Celle, E S D'amore, et al.
Bone Marrow Transplantation|January 1, 1989
Lymphokine activated killer (LAK) activity in lymphoproliferative disordersR Foa, M T Fierro, D Raspadori, et al.
The Journal of Experimental Medicine|March 1, 1987
Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemiaR Foa, G Casorati, M C Giubellino, et al.
Experimental Hematology|October 1, 1987
Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classificationR Foa, N Migone, M T Fierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alphaR Foa, A Guarini, P Francia di Celle, et al.
Genes, Chromosomes & Cancer|September 1, 1993
Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocationG Saglio, M Grazia Borrello, A Guerrasio, et al.
Blood|October 1, 1990
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectorsR Foa, M T Fierro, D Raspadori, et al.
American Journal of Clinical Pathology|October 1, 1979
Multiparameter studies in lymphoid leukemiasD Catovsky, S Pittman, M O'Brien, et al.
Immunology|December 1, 1996
Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cellsL Matera, G Bellone, J J Lebren, et al.
Haematologica|September 12, 2000
Unmanipulated peripheral blood stem cell autograft in chronic lymphocytic leukemia: clinical findings and biological monitoringG Meloni, A Proia, F Mauro, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|July 28, 2016
Cellular and Molecular Characterization of Two Cases of Castleman's Disease, Plasma Cell VariantS Roncella, P F Di Celle, E S D'amore, et al.
Bone Marrow Transplantation|January 1, 1989
Lymphokine activated killer (LAK) activity in lymphoproliferative disordersR Foa, M T Fierro, D Raspadori, et al.
The Journal of Experimental Medicine|March 1, 1987
Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemiaR Foa, G Casorati, M C Giubellino, et al.
Experimental Hematology|October 1, 1987
Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classificationR Foa, N Migone, M T Fierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alphaR Foa, A Guarini, P Francia di Celle, et al.
Genes, Chromosomes & Cancer|September 1, 1993
Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocationG Saglio, M Grazia Borrello, A Guerrasio, et al.
Blood|October 1, 1990
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectorsR Foa, M T Fierro, D Raspadori, et al.
American Journal of Clinical Pathology|October 1, 1979
Multiparameter studies in lymphoid leukemiasD Catovsky, S Pittman, M O'Brien, et al.
Immunology|December 1, 1996
Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cellsL Matera, G Bellone, J J Lebren, et al.
Haematologica|September 12, 2000
Unmanipulated peripheral blood stem cell autograft in chronic lymphocytic leukemia: clinical findings and biological monitoringG Meloni, A Proia, F Mauro, et al.
Pageof 18